Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voya Global Advantage and Premium Opportunity Fund

9.97
+0.03000.30%
Post-market: 9.970.00000.00%16:04 EDT
Volume:50.01K
Turnover:497.87K
Market Cap:181.45M
PE:6.64
High:9.98
Open:9.98
Low:9.93
Close:9.94
Loading ...

Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

Dow Jones
·
17 Jun

Voya Global Advantage And Premium Opportunity Fund Releases June 2025 Distribution Report

Reuters
·
16 Jun

Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

Dow Jones
·
16 May

Press Release: Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results

Dow Jones
·
13 May

Australian Oilseeds Issues Annual Shareholder Letter

GlobeNewswire
·
24 Apr

Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025

GlobeNewswire
·
22 Apr

Press Release: Voya Equity Closed End Funds Declare Distributions

Dow Jones
·
16 Apr

Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

Dow Jones
·
16 Apr

Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin and demonstrate favorable safety profile in a once daily pill

PR Newswire
·
10 Apr

AGS Ignites IGA 2025 with Next-Level Slot & Table Game Innovations

GlobeNewswire
·
28 Mar

Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

Dow Jones
·
18 Mar

Press Release: Voya Equity Closed End Funds Declare Distributions

Dow Jones
·
18 Mar

CyberArk Software (CYBR): Among the Best Cybersecurity Stocks to Buy According to Billionaires

Insider Monkey
·
11 Mar

Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis

PR Newswire
·
08 Mar

Dermata Announces that Last Patient Completes Last Visit in Pivotal XYNGARI™ Phase 3 STAR-1 Clinical Trial for Acne

PR Newswire
·
04 Mar

Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study

GlobeNewswire
·
27 Feb

Voya Equity Closed End Funds Declare Distributions

Business Wire
·
19 Feb

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Announces Payment of Monthly Distribution

Business Wire
·
19 Feb

CyberArk Acquires Zilla Security to Reshape Identity Governance and Administration for the Modern Enterprise

Business Wire
·
13 Feb

Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus

GlobeNewswire
·
11 Feb